Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model


Boston Scientific



) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 0.3%. By the end of trading, Boston Scientific rose 8 cents (1.3%) to $5.74 on light volume. Throughout the day, 8.7 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 13.3 million shares. The stock ranged in a price between $5.58-$5.75 after having opened the day at $5.63 as compared to the previous trading day's close of $5.66. Other companies within the Health Services industry that increased today were:

China Kanghui Holdings



), up 20.9%,

Dehaier Medical Systems



), up 15.5%,




), up 8.6%, and




), up 8.3%.

  • ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $7.96 billion and is part of the

health care

sector. Shares are up 5.1% year to date as of the close of trading on Thursday. Currently there are five analysts that rate Boston Scientific a buy, one analyst rates it a sell, and 15 rate it a hold.

TheStreet Ratings rates Boston Scientific as a


. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity and generally disappointing historical performance in the stock itself.

On the negative front,

Escalon Medical Corporation


TheStreet Recommends


), down 22.4%,

Allied Healthcare Products



), down 16%,




), down 6.5%, and

Harvard Bioscience



), down 6%, were all laggards within the health services industry with

UnitedHealth Group



) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR



) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care




FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge!

Free download now